肾移植急性排斥反应的评估与治疗
过去五十年免疫抑制治疗显著降低了肾移植受者的急性排斥反应率,但不明原因移植物功能障碍仍需高度警惕急性排斥。了解移植前后危险因素有助评估免疫性损伤概率,准确识别排斥类型和严重程度可指导治疗。组织活检仍是评估免疫性移植物损伤的金标准,组织学定义近年不断演变。静脉激素和T细胞清除仍是T细胞介导排斥的标准治疗,血浆置换联合静脉Ig(可加用利妥昔单抗)常用于抗体介导排斥。
要点
- 不明原因移植物功能障碍应高度怀疑急性排斥,组织活检是评估金标准。
- 静脉激素和T细胞清除是T细胞介导排斥的标准治疗,多数可逆转。
- 血浆置换联合静脉Ig(可加用利妥昔单抗)常用于抗体介导排斥。
核心结论
- 急性排斥仍是肾移植受者不明原因移植物功能障碍的重要鉴别诊断,准确分型指导治疗。
研究设计与样本
- 综述,面向照护移植受者的普通肾内科医生,总结免疫风险评估及急性排斥诊断治疗进展。
主要发现
- 过去五十年免疫抑制治疗显著改善了肾移植受者的急性排斥反应率。
- 组织活检仍是评估免疫性移植物损伤的金标准,急性排斥的组织学定义近年有所演变。
- 静脉激素和T细胞清除是T细胞介导排斥的标准治疗,多数病例可逆转。
- 血浆置换联合静脉Ig(可加用利妥昔单抗)最常用于抗体介导排斥的治疗。
- 多种新型药物近期已在严重病例中开展研究。
临床怎么用
- 对不明原因移植物功能障碍应高度怀疑急性排斥,及时行组织活检明确类型和严重程度。
- 根据排斥类型选择治疗:T细胞介导排斥用静脉激素和T细胞清除;抗体介导排斥用血浆置换联合静脉Ig(可加用利妥昔单抗)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Advances in immunosuppressive therapy have drastically improved acute rejection rates in kidney transplant recipients over the past five decades. Nevertheless, it should remain high on any differential diagnosis of unexplained graft dysfunction because of the potential negative effect on graft longevity. Understanding the pre- and post-transplant risk factors for acute rejection can help estimate the probability of immunologic graft damage, and accurate identification of the type and severity of acute rejection will guide appropriate treatment. Tissue biopsy remains the gold standard for evaluating immunologic graft damage, and the histologic definition of acute rejection has evolved in recent years. Intravenous steroids and T cell depletion remain the standard therapy for T cell-mediated rejection and are effective in reversing most cases. Plasma exchange and intravenous Ig, with or without rituximab, are most commonly used for the treatment of antibody-mediated rejection and several newer agents have recently been investigated for severe cases. This review aims to provide the general nephrologist caring for transplant recipients with an approach to immunologic risk assessment and a summary of recent advances in the diagnosis and treatment of acute graft rejection.
引用
- Cooper JE. Evaluation and Treatment of Acute Rejection in Kidney Allografts. Clin J Am Soc Nephrol. 2020. PMID: 32066593. doi:10.2215/CJN.11991019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。